JUDITH BASKIN: Open Payments
NPI 1558330670 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 80 payments from 12 companies in 2025. Trend: 2023 $419 · 2024 $1,202 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 33 | $316 |
| Amgen Inc. | 10 | $202 |
| E.R. Squibb & Sons, L.L.C. | 8 | $142 |
| Alnylam Pharmaceuticals Inc. | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Novo Nordisk Inc | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $76 |
| PFIZER INC. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: LEQVIO, REPATHA, CAMZYOS, AMVUTTRA, ELIQUIS, Wegovy, JARDIANCE, Kerendia.
Industry payments across TN — which companies pay providers there.
